Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Tivozanib
Tivozanib
475108-18-0
|
454.863
|
4.616
Tivozanib is a tyrosine kinase inhibitor that exerts its actions by inhibiting the phosphorylation of vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2 and VEGFR-3 and inhibits other kinases such as c-kit and platelet derived growth factor beta. Tivozanib is used to treat adult patients with renal cell carcinoma who have failed prior systemic therapies or experienced relapsed disease.
Av-951 | KRN951 | tivozanib
Tivozanib is a tyrosine kinase inhibitor that exerts its actions by inhibiting the phosphorylation of vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2 and VEGFR-3 and inhibits other kinases such as c-kit and platelet derived growth factor beta. Tivozanib is used to treat adult patients with renal cell carcinoma who have failed prior systemic therapies or experienced relapsed disease.
Av-951 | KRN951 | tivozanib
$67/5 mg
(EBC)
1
CAS:682745-41-1
0
CAS:682745-43-3
0
We provide 0 compound for Tivozanib